Screen: Light | Dark TEXT SIZE 1-855-GOSCENIC
SCENIC Clinical Trials hero image
All travel for study-related assessments will be provided for eligible study participants and their caregiver (if applicable).

ABOUT THE SCENIC CLINICAL TRIALS

  • The SCENIC clinical trials are studying an investigational (not yet FDA-approved) gene therapy called AGTC-501 for patients with X-linked retinitis pigmentosa (XLRP).
  • Gene therapy is the process of injecting a healthy gene to replace a damaged or mutated one.
  • The investigational gene therapy (AGTC-501) is designed to replace the mutated RPGR gene that causes XLRP.
  • The purpose of the SCENIC clinical trials is to evaluate the safety and effectiveness of AGTC-501 and to determine whether it may help a person with XLRP see better or maintain their current vision.

YOU OR YOUR CHILD MAY BE ELIGIBLE FOR ONE OF THE SCENIC CLINICAL TRIALS IF

Diagnosed with XLRP

Diagnosed with XLRP and have RPGR gene mutation
(confirmed by genetic testing)

Visual acuity in at least one eye between 20/32 and 20/200

Visual Acuity is between 20/32 and 20/200

Are male

Male

Are between the ages of 8 and 50

Between 8 and 50 years of age

Play our video image
Play our Video on Clinical Study Participation

SCENIC CLINICAL TRIAL PARTICIPATION

Clinical research studies help scientists and doctors explore whether a medical therapy is safe and effective in humans. The data gathered from clinical research helps the development of medical therapies, which may improve how patients receive medical care and the way they are treated for their conditions.

There is no guarantee that this investigational gene therapy will improve you or your child’s XLRP symptoms, but what researchers learn may lead to better medications and treatments for patients with XLRP in the future.

FOR HEALTHCARE PROFESSIONALS

Receive additional information about the SCENIC clinical trials. Learn More.

Think you have a patient that might qualify for one of the SCENIC clinical trials?

Refer a specialist that treats patients with RP or XLRP